+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antibiotics Market by Product Type, Route Of Administration, Type, Distribution Channel, Application, Spectrum - Global Forecast to 2030- Product Image
Antibiotics Market by Product Type, Route Of Administration, Type, Distribution Channel, Application, Spectrum - Global Forecast to 2030- Product Image
Sale

Antibiotics Market by Product Type, Route Of Administration, Type, Distribution Channel, Application, Spectrum - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5264378
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antibiotics Market grew from USD 45.74 billion in 2024 to USD 48.94 billion in 2025. It is expected to continue growing at a CAGR of 6.93%, reaching USD 68.40 billion by 2030.

Evolving Dynamics in the Global Antibiotics Ecosystem

The global antibiotics industry stands at a critical juncture, shaped by the convergence of scientific innovation, geopolitical dynamics, and evolving healthcare demands. As the prevalence of resistant pathogens escalates, the imperative for robust antimicrobial agents intensifies, driving stakeholders across the value chain to reevaluate priorities. In response, pharmaceutical developers are accelerating research into novel compounds while regulatory bodies worldwide tighten approval pathways and stewardship regulations.

Against this dynamic backdrop, suppliers and distributors are reconfiguring supply networks to ensure uninterrupted access to essential therapies, even as raw material fluctuations and logistical challenges persist. Simultaneously, healthcare providers confront the dual challenge of optimizing treatment efficacy and mitigating resistance, leading to increased adoption of diagnostic-guided prescribing and personalized dosing strategies. This executive summary distills the most critical developments, offering decision-makers a clear line of sight into the trends, tariff impacts, market segmentation insights, regional dynamics, competitive landscape, and actionable recommendations that will define the antibiotics market’s trajectory in 2025 and beyond.

Breakthrough Innovations and Collaborative Models Reshaping Antibiotic Development

The antibiotics landscape is experiencing transformative shifts driven by breakthroughs in molecular science and changing stakeholder imperatives. Advances in genomic screening and AI-driven drug design have streamlined the identification of new antibiotic candidates, fostering a wave of next-generation compounds poised to address multi-drug resistant organisms. Concurrently, public-private partnerships have become instrumental in de-risking early-stage research, accelerating the translation of laboratory innovations into clinical pipelines.

Market entrants are adopting differentiated strategies, such as targeted spectrum agents and combination therapies, to fill pipeline gaps and extend patent life cycles. Meanwhile, digital health platforms are empowering clinicians with real-time surveillance data, enabling more precise antibiotic stewardship and reducing unnecessary prescriptions. Collectively, these shifts are recalibrating competitive advantages, compelling established players to reinforce R&D investments and embrace collaborative models that span biotechnology firms, academic institutions, and government agencies.

Assessing the 2025 US Tariff Effects on Antibiotic Supply and Pricing

The imposition of new United States tariffs in 2025 has introduced additional layers of complexity into cross-border trade for antibiotic raw materials and finished formulations. With levies targeting key imported active pharmaceutical ingredients and certain finished dosage forms, manufacturers have encountered margin pressures that necessitate cost reengineering and strategic sourcing adjustments. In response, some producers have diversified procurement channels, forging alliances with suppliers in tariff-exempt regions to mitigate price volatility and preserve competitiveness.

In parallel, downstream distributors and healthcare institutions have absorbed partial cost increases, leading to modest upward pressure on end-user prices. This has prompted payers and procurement agencies to intensify tender negotiations and explore pricing agreements that align with budgetary constraints. Overall, the cumulative tariff impact underscores the importance of agile supply chain strategies and collaborative contracting mechanisms to safeguard access to vital antibiotics while sustaining industry resilience.

Deep Dive into Market Segmentation Revealing Growth Drivers

The antibiotics market exhibits intricate segmentation that informs product development, marketing strategies, and distribution models. Based on product type, the landscape encompasses aminoglycosides, beta lactams, macrolides, sulfonamides, and tetracyclines. Within the beta lactam category, the spectrum extends to carbapenems, cephalosporins, monobactams, and penicillins, with cephalosporins further delineated into first through fifth generation subgroups reflecting incremental potency and resistance profiles.

When viewed through the lens of route of administration, oral therapies dominate in outpatient settings, while parenteral formulations remain indispensable in hospital environments. Topical treatments serve niche applications such as dermatological infections. The market also stratifies by type, distinguishing natural, semi-synthetic, and synthetic antibiotics, a classification that impacts cost structures, patent lifecycles, and R&D complexity. Distribution channels bifurcate into hospital pharmacy, online pharmacy, and retail pharmacy networks, each with distinct procurement cycles and regulatory considerations. In terms of application, the market caters to both human healthcare and veterinary segments, the latter driven by livestock health management and companion animal care. Finally, spectrum classification separates broad-spectrum agents, which target a wide range of pathogens, from narrow-spectrum options that focus on specific bacterial strains, influencing stewardship practices and prescribing guidelines.

Regional Variations Shaping Antibiotic Demand and Supply Patterns

Regional dynamics in the antibiotics market are shaped by diverse regulatory frameworks, healthcare infrastructure maturity, and epidemiological patterns. In the Americas, innovation hubs and large pharmaceutical incumbents drive robust R&D pipelines, while concentrated healthcare budgets and advanced reimbursement systems support rapid adoption of novel therapies. North American initiatives on antibiotic stewardship and resistance surveillance set benchmarks for cost containment and clinical outcomes.

Europe, the Middle East & Africa present a heterogeneous environment, where leading EU nations balance progressive regulatory incentives with stringent pricing controls. In the Middle East, investment in healthcare infrastructure fuels demand for both generics and branded antibiotics, whereas Africa contends with access challenges, supply constraints, and a growing focus on combating resistant infections. In the Asia-Pacific region, vast population bases and rising healthcare expenditure in emerging economies are catalyzing increased antibiotic consumption. Simultaneously, local manufacturing capabilities in countries like China and India support large-scale production, influencing global supply flows and pricing dynamics.

Competitive Landscape Defined by Scale, Innovation, and Collaboration

The competitive landscape is dominated by a mix of legacy pharmaceutical giants and specialized biotechnology firms that focus on niche antibiotic classes. Established companies leverage extensive manufacturing infrastructure and global distribution networks to maintain leadership in core product lines. Their strategies often include lifecycle management approaches such as combination therapies and extended-release formulations to offset generic erosion.

Innovative biotech players contribute frontier research in areas like novel mechanism-of-action compounds and targeted delivery systems. These firms frequently collaborate with academic centers and government consortia to accelerate clinical validation and regulatory approval. At the same time, contract manufacturing organizations have expanded their capabilities to provide end-to-end solutions for small and mid-size enterprises, reflecting an ecosystem-wide trend toward outsourcing non-core operations. Collectively, these competitive forces drive consolidation, partnerships, and mergers as companies seek scale, access to complementary technologies, and optimized cost structures in a market increasingly defined by both price sensitivity and scientific advancement.

Strategic Actions to Bolster Growth and Foster Market Resilience

To navigate the evolving antibiotics market effectively, industry leaders should prioritize targeted research investments in areas demonstrating high unmet need, particularly where resistance rates are escalating. Shifting R&D focus toward narrow-spectrum agents and adjunctive therapies can differentiate portfolios and support stewardship objectives. Meanwhile, establishing strategic alliances with diagnostic providers will strengthen value propositions by enabling precision prescribing and outcome tracking.

Operationally, companies must optimize supply chains by diversifying sourcing regions and implementing digital tracking systems to enhance visibility and risk mitigation. Engaging early with payers and procurement bodies to secure outcome-based agreements can alleviate pricing pressures and reinforce long-term market access. Additionally, proactive engagement with regulatory authorities to shape favorable policy frameworks and expedited pathways will accelerate time to market. By integrating these approaches, leaders can bolster resilience, sustain growth, and contribute to global health imperatives.

Robust Research Design Ensuring Comprehensive Market Insight

The findings presented in this executive summary are grounded in a rigorous research framework combining primary and secondary data sources. Interviews with key industry stakeholders, including pharmaceutical executives, healthcare providers, and procurement specialists, provided qualitative insights into strategic priorities and market challenges. In parallel, secondary research encompassed regulatory filings, peer-reviewed journals, company financial statements, and trade publications to ensure comprehensive coverage of trend dynamics.

Quantitative analysis involved synthesis of historical data on antibiotic consumption, pricing patterns, and tariff schedules. Geographic segmentation and competitor profiling were derived from proprietary databases and validated through expert peer review. Triangulation of data points ensured accuracy and consistency, while scenario analysis assessed potential outcomes under varying regulatory and market conditions. This methodological approach yields robust insights that inform strategic decision-making across the antibiotics value chain.

Synthesis of Market Forces Guiding the Future of Antibiotics

The antibiotics sector is at an inflection point where scientific breakthroughs converge with complex regulatory and geopolitical forces. Tariff shifts and evolving stewardship imperatives are reshaping supply chains, pricing structures, and development priorities. Segmentation analysis highlights distinct growth pockets across product types, administration routes, and regional markets. Competitive dynamics underscore the importance of scale, innovation partnerships, and agile operational models.

Moving forward, the ability to anticipate resistance trends, collaborate across public and private sectors, and secure adaptive regulatory pathways will define industry leaders. By leveraging precise data analytics and fostering strategic alliances, stakeholders can navigate uncertainty, drive sustainable profitability, and ultimately safeguard patient outcomes worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Aminoglycosides
    • Beta Lactams
      • Carbapenems
      • Cephalosporins
        • Fifth Generation
        • First Generation
        • Fourth Generation
        • Second Generation
        • Third Generation
      • Monobactams
      • Penicillins
    • Macrolides
    • Sulfonamides
    • Tetracyclines
  • Route Of Administration
    • Oral
    • Parenteral
    • Topical
  • Type
    • Natural
    • Semi Synthetic
    • Synthetic
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • Application
    • Human
    • Veterinary
  • Spectrum
    • Broad Spectrum
    • Narrow Spectrum
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi SA
  • Novartis AG
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • AstraZeneca plc
  • Bayer AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antibiotics Market, by Product Type
8.1. Introduction
8.2. Aminoglycosides
8.3. Beta Lactams
8.3.1. Carbapenems
8.3.2. Cephalosporins
8.3.2.1. Fifth Generation
8.3.2.2. First Generation
8.3.2.3. Fourth Generation
8.3.2.4. Second Generation
8.3.2.5. Third Generation
8.3.3. Monobactams
8.3.4. Penicillins
8.4. Macrolides
8.5. Sulfonamides
8.6. Tetracyclines
9. Antibiotics Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.3. Parenteral
9.4. Topical
10. Antibiotics Market, by Type
10.1. Introduction
10.2. Natural
10.3. Semi Synthetic
10.4. Synthetic
11. Antibiotics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Antibiotics Market, by Application
12.1. Introduction
12.2. Human
12.3. Veterinary
13. Antibiotics Market, by Spectrum
13.1. Introduction
13.2. Broad Spectrum
13.3. Narrow Spectrum
14. Americas Antibiotics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Antibiotics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Antibiotics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. GlaxoSmithKline plc
17.3.3. Sanofi SA
17.3.4. Novartis AG
17.3.5. Merck & Co., Inc.
17.3.6. Johnson & Johnson
17.3.7. Teva Pharmaceutical Industries Ltd.
17.3.8. Sandoz International GmbH
17.3.9. AstraZeneca plc
17.3.10. Bayer AG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ANTIBIOTICS MARKET MULTI-CURRENCY
FIGURE 2. ANTIBIOTICS MARKET MULTI-LANGUAGE
FIGURE 3. ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY FIFTH GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY FOURTH GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY MONOBACTAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIBIOTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY SEMI SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIBIOTICS MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIBIOTICS MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD SPECTRUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW SPECTRUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. CANADA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 61. CANADA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 62. CANADA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. CANADA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. CANADA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 67. MEXICO ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 108. GERMANY ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 110. GERMANY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 111. GERMANY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. GERMANY ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. GERMANY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. GERMANY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. GERMANY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 116. FRANCE ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FRANCE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 132. ITALY ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 134. ITALY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 135. ITALY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. ITALY ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. ITALY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. ITALY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 140. SPAIN ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SPAIN ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 142. SPAIN ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 143. SPAIN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. SPAIN ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. SPAIN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. SPAIN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. SPAIN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 172. DENMARK ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. DENMARK ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 174. DENMARK ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 175. DENMARK ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. DENMARK ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. DENMARK ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. DENMARK ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. DENMARK ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 188. QATAR ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 190. QATAR ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 191. QATAR ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. QATAR ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. QATAR ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. QATAR ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. QATAR ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 196. FINLAND ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. FINLAND ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. FINLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. FINLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. FINLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 220. EGYPT ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 223. EGYPT ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. EGYPT ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. EGYPT ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. EGYPT ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. EGYPT ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 228. TURKEY ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 231. TURKEY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. TURKEY ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. TURKEY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. TURKEY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. TURKEY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 244. NORWAY ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. NORWAY ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. NORWAY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. NORWAY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. NORWAY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 252. POLAND ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. POLAND ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 254. POLAND ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 255. POLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. POLAND ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. POLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. POLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. POLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 277. CHINA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. CHINA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 279. CHINA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 280. CHINA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. CHINA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. CHINA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. CHINA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. CHINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 285. INDIA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. INDIA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 287. INDIA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 288. INDIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. INDIA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 290. INDIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. INDIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. INDIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 293. JAPAN ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 296. JAPAN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. JAPAN ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 298. JAPAN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. JAPAN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. JAPAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 325. THAILAND ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 327. THAILAND ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 328. THAILAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 329. THAILAND ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 330. THAILAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 331. THAILAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. THAILAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 345. MALAYSIA ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 346. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 347. MALAYSIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 348. MALAYSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 352. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 353. SINGAPORE ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 354. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 355. SINGAPORE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 356. SINGAPORE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 358. VIETNAM ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 359. VIETNAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 360. VIETNAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 361. VIETNAM ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 362. VIETNAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 363. VIETNAM ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 364. VIETNAM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 365. TAIWAN ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 366. TAIWAN ANTIBIOTICS MARKET SIZE, BY BETA LACTAMS, 2018-2030 (USD MILLION)
TABLE 367. TAIWAN ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 368. TAIWAN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 369. TAIWAN ANTIBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 370. TAIWAN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 371. TAIWAN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 372. TAIWAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
TABLE 373. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 374. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Antibiotics market report include:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi SA
  • Novartis AG
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • AstraZeneca plc
  • Bayer AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 48.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 68.4 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antibiotic Resistance Market by Product Type, Test Type, Application, End Use, Resistance Mechanism - Global Forecast to 2030 - Product Image

Antibiotic Resistance Market by Product Type, Test Type, Application, End Use, Resistance Mechanism - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Semi-synthetic ß-lactam Antibiotics Market - Global Forecast to 2030 - Product Image

Semi-synthetic ß-lactam Antibiotics Market - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2024-2032 - Product Image

Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
Antibiotic Resistance - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Antibiotic Resistance - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.